Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Aspen Neuroscience has raised $115.0M in total funding. The most recent round was Series C. The last funding was announced in November 2025.
Aspen Neuroscience's investors include Gaingels, OrbiMed, ARCH Venture Partners, Cormorant Asset Management, S32.
Aspen Neuroscience is headquartered in San Diego, United States.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Aspen Neuroscience is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aspen Neuroscience — Funding & Investors." VCBacked, November 20, 2025, https://www.vcbacked.co/company/aspen-neuroscience. Accessed October 29, 2026.
VCBacked. (2025). Aspen Neuroscience — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/aspen-neuroscience
{{cite web |title=Aspen Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/aspen-neuroscience |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated